Jared E. Lopes

2.5k total citations · 1 hit paper
14 papers, 2.1k citations indexed

About

Jared E. Lopes is a scholar working on Immunology, Oncology and Biotechnology. According to data from OpenAlex, Jared E. Lopes has authored 14 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Oncology and 3 papers in Biotechnology. Recurrent topics in Jared E. Lopes's work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (5 papers). Jared E. Lopes is often cited by papers focused on Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (5 papers). Jared E. Lopes collaborates with scholars based in United States, Canada and India. Jared E. Lopes's co-authors include Steven F. Ziegler, Jianguang Du, Gabriel D. Victora, Dan R. Littman, Ivaylo I. Ivanov, Alexander Y. Rudensky, Mark M. W. Chong, Yuelei Shen, Yury P. Rubtsov and Liang Zhou and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Jared E. Lopes

12 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function

2008 1.5k citations Liang Zhou, Jared E. Lopes et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jared E. Lopes United States	9	1.6k	378	357	204	127	14	2.1k
Tom McNeil United States	7	1.7k 1.1×	515 1.4×	366 1.0×	111 0.5×	120 0.9×	7	2.3k
Kevin C. Conlon United States	25	1.5k 1.0×	1.2k 3.1×	362 1.0×	161 0.8×	87 0.7×	58	2.5k
Ellen J. Beswick United States	27	951 0.6×	500 1.3×	326 0.9×	151 0.7×	85 0.7×	53	1.8k
Giovanna Carrà Italy	20	1.1k 0.7×	365 1.0×	580 1.6×	112 0.5×	221 1.7×	59	1.9k
Ιoannis Kotsianidis Greece	23	809 0.5×	303 0.8×	795 2.2×	157 0.8×	64 0.5×	113	2.2k
Natalia Martín‐Orozco United States	22	2.1k 1.3×	968 2.6×	405 1.1×	405 2.0×	105 0.8×	30	2.8k
Theresa Truitt United States	10	1.0k 0.7×	356 0.9×	255 0.7×	100 0.5×	64 0.5×	10	1.4k
Wook Lew South Korea	10	950 0.6×	356 0.9×	341 1.0×	97 0.5×	117 0.9×	31	1.6k
Renata B. Filler United States	24	2.0k 1.3×	815 2.2×	344 1.0×	97 0.5×	100 0.8×	36	2.6k
Sören T. Eichhorst Germany	17	780 0.5×	483 1.3×	596 1.7×	196 1.0×	137 1.1×	19	1.7k

Countries citing papers authored by Jared E. Lopes

Since Specialization

Citations

This map shows the geographic impact of Jared E. Lopes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jared E. Lopes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jared E. Lopes more than expected).

Fields of papers citing papers by Jared E. Lopes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jared E. Lopes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jared E. Lopes. The network helps show where Jared E. Lopes may publish in the future.

Co-authorship network of co-authors of Jared E. Lopes

This figure shows the co-authorship network connecting the top 25 collaborators of Jared E. Lopes. A scholar is included among the top collaborators of Jared E. Lopes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jared E. Lopes. Jared E. Lopes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Phoon, Yee Peng, Jared E. Lopes, Lukas W. Pfannenstiel, et al.. (2024). Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeutics. Journal for ImmunoTherapy of Cancer. 12(4). e008066–e008066. 2 indexed citations

Vaishampayan, Ulka N., Shipra Gandhi, Anna Spreafico, et al.. (2022). Nemvaleukin alfa combination therapy for gastrointestinal (GI) cancers: Preclinical evidence and clinical data from the ARTISTRY-1 trial.. Journal of Clinical Oncology. 40(4_suppl). 659–659.

Lopes, Jared E., et al.. (2021). Pharmacokinetics and Pharmacodynamic Effects of Nemvaleukin Alfa, a Selective Agonist of the Intermediate-Affinity IL-2 Receptor, in Cynomolgus Monkeys. Journal of Pharmacology and Experimental Therapeutics. 379(2). 203–210. 15 indexed citations

Lopes, Jared E., Jan L. Fisher, Chunhua Wang, et al.. (2020). ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 8(1). e000673–e000673. 100 indexed citations

Lopes, Jared E., Rachel L. Dusek, Liliane Robillard, et al.. (2020). Abstract 2202: The combination of a mouse ortholog of ALKS 4230, a selective agonist of the intermediate affinity IL-2 receptor, and the angiogenesis inhibitor lucitanib enhances antitumor activity. Cancer Research. 80(16_Supplement). 2202–2202. 2 indexed citations

Losey, Heather C., et al.. (2017). Abstract 591: Efficacy of ALKS 4230, a novel immunotherapeutic agent, in murine syngeneic tumor models alone and in combination with immune checkpoint inhibitors. Cancer Research. 77(13_Supplement). 591–591. 3 indexed citations

Losey, Heather C., Jared E. Lopes, Reginald L. Dean, et al.. (2015). Abstract 4280: Utilizing a selective agonist of the intermediate-affinity IL-2 receptor with an improved pharmacokinetic profile leads to an enhanced immunostimulatory response With reduced toxicity in mice. Cancer Research. 75(15_Supplement). 4280–4280.

Yang, Siyoung, Kushagra Bansal, Jared E. Lopes, Christophe Benoıst, & Diane Mathis. (2013). Aire’s plant homeodomain(PHD)-2 is critical for induction of immunological tolerance. Proceedings of the National Academy of Sciences. 110(5). 1833–1838. 23 indexed citations

Zhou, Liang, Jared E. Lopes, Mark M. W. Chong, et al.. (2008). TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function. Nature. 453(7192). 236–240. 1533 indexed citations breakdown →

10.

Lopes, Jared E., et al.. (2007). Role of the extracellular and transmembrane domain of Ig-α/β in assembly of the B cell antigen receptor (BCR). Immunology Letters. 112(1). 47–57. 30 indexed citations

11.

Lopes, Jared E., David M. Soper, & Steven F. Ziegler. (2007). Foxp3 Is Required Throughout the Life of a Regulatory T Cell. Science s STKE. 2007(393). pe36–pe36. 15 indexed citations

12.

Lopes, Jared E., Troy R. Torgerson, Lisa Schubert, et al.. (2006). Analysis of FOXP3 Reveals Multiple Domains Required for Its Function as a Transcriptional Repressor. The Journal of Immunology. 177(5). 3133–3142. 214 indexed citations

13.

Way, Sing Sing, Lucas Thompson, Jared E. Lopes, et al.. (2004). Characterization of flagellin expression and its role in Listeria monocytogenes infection and immunity. Cellular Microbiology. 6(3). 235–242. 125 indexed citations

14.

Wang, Leo D., Jared E. Lopes, Anthony B. Cooper, et al.. (2004). Selection of B lymphocytes in the periphery is determined by the functional capacity of the B cell antigen receptor. Proceedings of the National Academy of Sciences. 101(4). 1027–1032. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact